Cargando…
Corrections required for Dressler and Johnson 2022
Autores principales: | Esquenazi, Alberto, Elliott, Mark, Lysandropoulos, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468082/ https://www.ncbi.nlm.nih.gov/pubmed/36040626 http://dx.doi.org/10.1007/s00702-022-02534-0 |
Ejemplares similares
-
Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020) -
Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020) -
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
por: Esquenazi, Alberto, et al.
Publicado: (2020) -
Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
por: Carranza, Octavio, et al.
Publicado: (2022) -
Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study
por: Jacinto, Jorge, et al.
Publicado: (2022)